Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Prestige Biopharma Limited

Clinical trials sponsored by Prestige Biopharma Limited, explained in plain language.

Prestige Biopharma Limited 950210 KRX

A biopharmaceutical company developing biosimilars and novel drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1 Completed 2

Can a targeted antibody slow advanced pancreatic cancer?

Disease control Ongoing

This trial tests an experimental antibody, PBP1510, designed to block a protein called PAUF that may help pancreatic cancer grow. The study includes two parts: first, finding a safe dose of PBP1510 alone or with the chemotherapy gemcitabine; second, testing the best dose in a lar…

Phase: PHASE1, PHASE2 • Sponsor: Prestige Biopharma Limited • Aim: Disease control

Last updated Jul 29, 2026 00:00 UTC